Presentation Early Regression of Severe LV Hypertrophy After TAVR Is Associated with Decreased Hospitalizations Presenter: Brian R. Lindman June 25, 2014 REGISTER for free or LOG IN to view this content Aortic Valve Factoid Up Next Presentation PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy Presenter: David R. Holmes Jr. June 30, 2014 More slides + Presentation Three-Year Outcomes after TAVR with the CoreValve Prosthesis Presenter: Michael Gotzmann June 30, 2014 Presentation CTO 2013 Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging Presenter: Antonio Colombo February 22, 2013 We Recommend
Presentation PREVAIL: Prospective Randomized Evaluation of the Watchman LAA Closure Device in Patients with A-fib vs Long-term Warfarin Therapy Presenter: David R. Holmes Jr. June 30, 2014
Presentation Three-Year Outcomes after TAVR with the CoreValve Prosthesis Presenter: Michael Gotzmann June 30, 2014
Presentation CTO 2013 Case 9: Complex Left Main with Multivessel Disease: Technical Approach and Role of Staging Presenter: Antonio Colombo February 22, 2013